Beckman Profit Falls on News of Settlement
- Share via
Beckman Coulter Inc., which sells equipment and tests to medical laboratories and drug makers, said on Monday that fourth-quarter profit fell because of a patent-infringement settlement.
Net income declined to $33.5 million, or 53 cents a share, from $48.3 million, or 75 cents, in the same period of 2001, the company said. Sales rose 3% to about $595.5 million from $578.3 million.
Beckman paid $23.8 million, or 37 cents a share, for a patent-infringement settlement with Streck Laboratories Inc. Excluding that expense, the company had a profit of about $57.3 million, or 90 cents a share, the company said.
On that basis, the company beat the 89-cent average estimate of five analysts surveyed by Thomson First Call.
The Fullerton-based company reported 2002 net income of $135.5 million, or $2.08 a share, and sales of about $2.1 billion.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
